Picard Medical, Inc.
PMI
$0.46
-$0.02-3.93%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.00% | -44.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.00% | -44.11% | |||
| Cost of Revenue | -54.59% | -41.49% | |||
| Gross Profit | 416.15% | -2.36% | |||
| SG&A Expenses | 19.16% | -9.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.16% | -17.20% | |||
| Operating Income | 13.88% | 0.97% | |||
| Income Before Tax | 58.88% | -55.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 58.84% | -55.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 58.84% | -55.06% | |||
| EBIT | 13.88% | 0.97% | |||
| EBITDA | 14.02% | 1.01% | |||
| EPS Basic | 69.61% | 71.59% | |||
| Normalized Basic EPS | 62.41% | 74.88% | |||
| EPS Diluted | 69.61% | 71.59% | |||
| Normalized Diluted EPS | 62.41% | 74.88% | |||
| Average Basic Shares Outstanding | 35.35% | 517.47% | |||
| Average Diluted Shares Outstanding | 35.35% | 517.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||